Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota
NCT ID: NCT02306980
Last Updated: 2017-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2013-10-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Care With Colostrum for Preventing Late-onset Sepsis in Preterm Infants
NCT06534632
Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial
NCT03926390
Effect of Colostrum on Mucosal Immunity in Very Low Birth Weight (VLBWs) Premature Infants
NCT01776268
Feeding Bovine Colostrum to Preterm Infants
NCT02054091
Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum
NCT05481866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colostrum
Colostrum administration
Colostrum
Mother's own colostrum (0.2 ml) will be administered into the mouth of the infant every 2 hours for 48 hours.
Control
Routine care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colostrum
Mother's own colostrum (0.2 ml) will be administered into the mouth of the infant every 2 hours for 48 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* intubated in the first 48 hours of life
* available maternal colostrum
Exclusion Criteria
12 Hours
7 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A Underwood, MD
Role: PRINCIPAL_INVESTIGATOR
UC Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis Children's Hospital
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sohn K, Kalanetra KM, Mills DA, Underwood MA. Buccal administration of human colostrum: impact on the oral microbiota of premature infants. J Perinatol. 2016 Feb;36(2):106-11. doi: 10.1038/jp.2015.157. Epub 2015 Dec 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
531791
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.